A Randomized Controlled Clinical Trial of Transcutaneous Auricular Point Electrical Stimulation for Improving Symptoms of Chronic Tic Disorders in Children/Adolescents

ConditionTic Disorder
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-18
SponsorThe First Affiliated Hospital of Zhejiang Chinese Medical University

About this trial

The objective of this trial is to evaluate the effect of transcutaneous auricular point electrical stimulation compared to the micro-stimulation in the treatment of chronic tic disorder in adolescents

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transcutaneous Auricular Point Electrical Stimulation

    Device

    Participants in the Transcutaneous Auricular Point Electrical Stimulation group will receive Transcutaneous Auricular Point Electrical Stimulation 5 a week, with each session lasting 30 minutes. The treatment will start from the time of enrollment and lasting for 8 weeks.

  • micro-stimulation

    Device

    Participants in the Transcutaneous Auricular Point Electrical Stimulation group will receive Transcutaneous Auricular Point Electrical Stimulation 5 a week, with each session lasting 30 minutes. The treatment will start from the time of enrollment and lasting for 8 weeks.

Treatment groups

124 Participants
are divided into 2 treatment groups
Group A: Transcutaneous Auricular Point Electrical StimulationExperimental treatment 2 interventions
Group B: micro-stimulationSham comparator 2 interventions

Trial outcomes

Primary outcomes

1

Yale Global Tic Severity Scale Total Tic Score

Time frame
baseline (Week 0), during treatment (Week 4), and after treatment (Week 8), with a follow-up period of 4 weeks after the end of treatment (Week 12)

Secondary outcomes

1

Change in YGTSS-TTS score from baseline

Time frame
week 4,week12
2

Change in YGTSS scores across other dimensions relative to baseline

Time frame
week 4,week 8,week 12
3

Children's Yale-Brown Obsessive Compulsive Scale

Time frame
Week 0, Week 4, Week 8, Week 12
4

Swanson, Nolan, and Pelham-IV-18

Time frame
Week 0, Week 4, Week 8, Week 12

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: